HAL vs SUPN · P/E 9.3, $19.05B cap vs rev $661.8M
Halliburton Company (HAL) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the HAL and SUPN stock pages for the full models.
Not investment advice.